Chromosomal abnormalities in myelodysplastic syndrome;Alterações cromossômicas em síndrome mielodisplásica

Revista Brasileira de Hematologia e Hemoterapia

Volumn 28, Issue 3, 2006, Pages 182-187

  Chauffaille, Maria De Lourdes L F ^a,b,c  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Fleury   (Brazil)

^c NONE   (Brazil)

Author keywords

Chromosome; Karyotype; Myelodysplasic syndrome; Prognosis

Indexed keywords

EID: 33846915921     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-84842006000300006     Document Type: Article

References (12)

1. Chauffaille MLLF. Anormalidades citogenéticas em leucemia mielóide aguda, síndrome mielodisplásica, síndrome mieloproliferativa e anemia de Fanconi. In Lorenzi TF. Atlas de Hematologia: clínica hematológica ilustrada. Rio de Janeiro, Guanabara Koogan, 2006.
2. Barch MJ, Knutsen T, Spurbeck. The AGT Cytogenetics Laboratory Manual, 3rd ed Lippinctt-Raven, Philadelphia, 1997.
3. ISCN 2005: An International System for Human Cytogenetics Nomenclature, Recommendations of the International Standing Committee on Human Cytogenetic Nomenclature. Published in collaboration with 'Cytogenetic and Genome Research' Editor(s): Shaffer LG. (Spokane, Wash.); Tommerup N. (Copenhagen),
4. Romeo M, Chauffaille ML, Silva MRR, Bahia DMM, Kerbauy J. Comparison of cytogenetics with FISH in 40 MDS patients. Leuk Res 2002; 26: 993-6.
5. Chauffaille MLLF. A importância de citogenética em LMA e em SMD. Tese de Livre-docência 2003. Hematologia Unifwap/EPM.
6. Pinheiro RF, Chauffaille MLLF, Silva MRR. Isochromosome 17q in MDS: a marker of a distinct entity. Cancer Genetic and Cytogenetics 2006 (in press).
7. Greenberg P, Cox C, Le Beau MM, et al. International scoring system for evaluation prognosis of myelodysplastic syndrome: a multivariate analysis of prognosis in MDS. Blood 1997, 89:2079-88.
8. Malcovati L, Germing U, Kuendgen A, Porta MD, Invernizzi R, Giagouinidis A, et al. A WHO classification-based scoring system (WPSS) for predicting survival in MDS. Blood 2005 106(11): 232a, abstract #788.
9. Solé F, Luño E, Sanzo C, Espinet B, Sanz GF, Cervera J, et al. Identification of novel cytogenetics markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndrome. Haematoligca 2005:90: 1.168-78.
10. List A, Kurtin S, Roe DJ, Buresh A, Mahadevan D, Fuchs D, et al. Efficacy of lenalidomide in MDS. The New Engl J of Med 2005 352(6): 549-57.
11. Pinheiro RF, Silva, MRR, Chauffaille MLF. The 5q- syndrome and autoimmune phenomena: report of three cases. Leuk Res 2006 (30): 507-510.
12. Chauffaille MLLF, Stefano JT, Valério RM, Romeo M, Rodrigues MM, Kerbauy J. del 11q23 as a prognostic factor of iron overload in refractory anemia with ringed sideroblasts. SP Med Journ 1997, 115(4): 1.513-1.516.